|
⚲
|
| Keyboard |
| Burgess Daniel D
✚
|
|
|---|---|
| CIK # | 0001239650 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001239650] | |
| 4 | [0001239650] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Burgess Daniel D | |
| K2 Therapeutics Inc | |
| Arbutus Biopharma Corp | |
| Nabriva Therapeutics AG | |
| Nabriva Therapeutics Legacy PLC | |
| Santarus Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K2 Therapeutics Inc CDTX
Common Stock
|
2026-01-07 | Disposed to issuer | 150 | $221.50 | 33,225 |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 20,500 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 11,100 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 450 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,400 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 11,100 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-12-17 | Grant | 20,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-07-18 | Grant | 2,125 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 67,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 42,500 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2023-05-24 | Grant | 55,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2022-08-02 | Sell | 11,341 | $0.19 | 2,155 |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 28,000 | $0.00 | |
| showing 20 of 77 most recent transactions | |||||